1236 related items for PubMed ID: 18405796
1. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE, Hagiwara M, Stanford RH, Stempel DA.
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[Abstract] [Full Text] [Related]
2. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
Stempel DA, Riedel AA, Carranza Rosenzweig JR.
Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
[Abstract] [Full Text] [Related]
3. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR.
J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
[Abstract] [Full Text] [Related]
4. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[Abstract] [Full Text] [Related]
5. Adherence to asthma controller medication regimens.
Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.
Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
[Abstract] [Full Text] [Related]
6. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS, Yawn BP.
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[Abstract] [Full Text] [Related]
7. Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens.
O'Connor RD, Rosenzweig JR, Stanford RH, Gilmore AS, Ryskina KL, Legorreta AP, Stempel DA.
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):535-40. PubMed ID: 16400892
[Abstract] [Full Text] [Related]
8. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM, Culler SD, Ershoff D, Gutierrez B.
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[Abstract] [Full Text] [Related]
9. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L.
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[Abstract] [Full Text] [Related]
10. Risk of asthma exacerbation, asthma-related health care utilization and costs, and adherence to controller therapy in patients with asthma receiving fluticasone propionate/salmeterol inhalation powder 100 μg/50 μg versus mometasone furoate inhalation powder.
Hagiwara M, Delea TE, Stanford RH.
J Asthma; 2013 Apr; 50(3):287-95. PubMed ID: 23305687
[Abstract] [Full Text] [Related]
11. Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population.
Stanford RH, Blanchette CM, Roberts MH, Petersen H, Fuhlbrigge AL.
Am J Geriatr Pharmacother; 2012 Dec; 10(6):343-51. PubMed ID: 23083688
[Abstract] [Full Text] [Related]
12. Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy.
Allen-Ramey FC, Bukstein D, Luskin A, Sajjan SG, Markson LE.
J Manag Care Pharm; 2006 May; 12(4):310-21. PubMed ID: 16792437
[Abstract] [Full Text] [Related]
13. Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
O'Connor RD, Gilmore AS, Manjunath R, Stanford RH, Legorreta AP, Jhingran PM.
Curr Med Res Opin; 2006 Mar; 22(3):453-61. PubMed ID: 16574029
[Abstract] [Full Text] [Related]
14. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[Abstract] [Full Text] [Related]
15. Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.
Hagiwara M, Delea TE, Stanford RH.
Allergy Asthma Proc; 2014 Sep; 35(1):54-62. PubMed ID: 24433597
[Abstract] [Full Text] [Related]
16. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL, Akazawa M, Johnsrud M, Stanford RH, Blanchette CM.
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[Abstract] [Full Text] [Related]
17. Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease.
Akazawa M, Hayflinger DC, Stanford RH, Blanchette CM.
Am J Manag Care; 2008 Jul; 14(7):438-48. PubMed ID: 18611095
[Abstract] [Full Text] [Related]
18. Comparative resource utilization in medicaid-eligible patients with asthma treated with fixed-dose fluticasone propionate/salmeterol or fluticasone propionate monotherapy.
Stanford RH, Riedel AA, Johnson JC, Astry CL.
Clin Ther; 2010 Sep; 32(10):1782-93. PubMed ID: 21194602
[Abstract] [Full Text] [Related]
19. Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.
Hagiwara M, Delea TE, Stanford RH, Stempel DA.
Allergy Asthma Proc; 2010 Sep; 31(3):203-10. PubMed ID: 20534183
[Abstract] [Full Text] [Related]
20. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
Rowe BH, Wong E, Blitz S, Diner B, Mackey D, Ross S, Senthilselvan A.
Acad Emerg Med; 2007 Oct; 14(10):833-40. PubMed ID: 17898245
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
